Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Multiple Myeloma 27Prostatic Neoplasms 25Carcinoma, Non-Small-Cell Lung 23Breast Neoplasms 23Leukemia, Myeloid, Acute 22Lymphoma 21Melanoma 17Lymphoma, Non-Hodgkin 16Ovarian Neoplasms 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Colorectal Neoplasms 13Wilms Tumor 11Neoplasms 11Neoplasm Metastasis 11Hodgkin Disease 11Myelodysplastic Syndromes 10Lung Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Sarcoma 9Glioma 9Fallopian Tube Neoplasms 9Carcinoma, Renal Cell 9Burkitt Lymphoma 9Rhabdomyosarcoma 8Rhabdoid Tumor 8Medulloblastoma 8Leukemia 8Hepatoblastoma 8Sarcoma, Ewing 7Osteosarcoma 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Glucose Intolerance × 30 days × Clear all
NCT05038137 2026-06-02

TREC

Medical University of South Carolina

Phase NA Completed
29 enrolled 16 charts
Breast

Intermittent Fasting, Breast Neoplasms, Glucose Intolerance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡